Foot (incl. plantar fasciitis, flat feet) decisions — 2025

The Board remands the claims for further development to ensure that the severity of the Veteran's disabilities is accurately assessed without considering the ameliorative effects of medications.

The Board granted service connection for irritable bowel syndrome and bilateral pes planus with plantar fasciitis based on the probative evidence linking these conditions to the Veteran's active service.

The Board denied the veteran's claims for increased ratings and a TDIU, as the evidence did not support higher ratings or unemployability due to service-connected disabilities.

The Board denied the veteran's request for an earlier effective date for the 10 percent disability evaluation for allergic rhinitis and bilateral plantar fasciitis, as it was not factually ascertainable that a worsening in these conditions occurred within one year of the December 26, 2023 intent to file.

The Board granted service connection for left foot plantar fasciitis, finding that it was secondary to the Veteran's service-connected right ankle sprain with instability.

The Board granted service connection for flat foot (pes planus) with plantar fasciitis, plantar fascial fibromatosis, and degenerative arthritis based on the evidence showing a relationship to military service.

The Board denied service connection for hearing loss in either ear but granted service connection for bilateral flatfoot (pes planus) as proximately due to the Veteran's service-connected right ankle disability.

The Board denied service connection for acid reflux, back pain, bilateral flat feet, left bunion, right bunion and right toe pain, 'black out frequency', right hip pain, bilateral hearing loss, tinnitus, and PTSD as there was no evidence of a current disability or sufficient evidence to support the claim.

The Board denied service connection for heart, hypertension, diabetes, insomnia, and foot disabilities as the evidence did not show current diagnoses or functional limitations related to these conditions during the appeal period.

The Board granted service connection for low back disability, diagnosed as spondylolisthesis at L4 and degenerative disc disease at L2-L3 and L4-L5. The left and right foot issues were remanded.

The Board denied service connection for multiple disabilities, including left wrist, lumbar spine, right hip, right leg, left leg, bilateral foot, and onychomycosis of the right foot.

The Board denied service connection for multiple foot, hip, knee, and ankle disabilities but granted service connection for tinnitus as secondary to a service-connected left ear hearing loss.

The Board granted service connection for bilateral pes planus, finding that the evidence supports a direct link between the Veteran's in-service injury and his current condition.

The Board denied an initial compensable evaluation for non-allergic rhinitis and remanded the claims for service connection for bilateral plantar fasciitis and chronic fatigue syndrome.

The Board remands the claims for a compensable rating of various foot conditions and service connection for left shoulder degenerative arthritis, other than post-traumatic, due to inadequate VA examinations.

The Board granted the readjudication of claims for service connection based on new and relevant evidence, but remanded other claims for further examination.

The Board granted service connection for headaches and left pes planus, but denied service connection for cervical disc herniation at C5-C6 level with posterior disc protrusion and Bell's palsy.

The Board granted service connection for bilateral pes planus and multiple sclerosis (MS) based on the Veteran's in-service environmental exposures.

The Board remands the Veteran's claims for service connection for various disabilities and a TDIU due to pre-decisional duty-to-assist errors.

The Board granted a 30 percent disability rating for the service-connected bilateral pes planus with plantar fasciitis from July 28, 2015 to November 27, 2023, but denied an increased rating in excess of 10 percent for the period from October 19, 2012 to July 28, 2015 and a rating in excess of 30 percent from November 27, 2023.